Combined-step process for pharmaceutical compositions

Details for Australian Patent Application No. 2006228947 (hide)

Owner Genpharm Inc.

Inventors Caron, David A.; Al-Bargash, Lina

Agent Davies Collison Cave

Pub. Number AU-A-2006228947

PCT Pub. Number WO2006/102750

Priority 2,505,463 30.03.05 CA

Filing date 30 March 2006

Wipo publication date 5 October 2006

International Classifications

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61J 3/07 (2006.01) Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms - into the form of capsules or similar small containers for oral use

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/102750 Priority application(s): WO2006/102750

23 October 2008 Alteration of Name

  The name of the applicant has been altered to Genpharm ULC

11 February 2010 Alteration of Name

  The name of the applicant has been altered to Mylan Pharmaceuticals ULC

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228949-Compositions for oral transmucosal delivery of metformin

2006228945-Intravenous formulations of pyridoxal 5'-phosphate and method of preparation